{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T09:47:36Z","timestamp":1774691256293,"version":"3.50.1"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:00:00Z","timestamp":1756944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>We describe an atypical presentation of Immune dysregulation, Polyendocrinopathy, Enteropathy, X-linked syndrome. The patient exhibited food allergies and eczema, along with recurrent and severe infections, but notably lacked the hallmark chronic diarrhea and autoimmune polyendocrinopathy. Whole-exome sequencing revealed the hemizygous <jats:italic>FOXP3<\/jats:italic> variant c.210+1G&amp;gt;T resulting in a loss of protein expression. Immunophenotyping showed an unusual overlap between immune deficiency and immune dysregulation. The patient had CD4<jats:sup>+<\/jats:sup> lymphopenia, with a marked reduction of na\u00efve CD4<jats:sup>+<\/jats:sup> T cells, and impaired T cell proliferation to specific antigens. Moreover, he had reduced serum levels of immunoglobulin (Ig) G2, IgA, and IgM, but high IgE levels and eosinophilia. Given these features consistent with a cellular and humoral immune defect predisposing to infections, the patient was treated with immunoglobulin replacement therapy, which was beneficial. We identified an altered immunophenotypic signature shared between T regulatory and T effector cells. This T helper 1-like memory phenotype corresponded to an increased secretion of interferon-\u03b3 following <jats:italic>ex vivo<\/jats:italic> stimulation of peripheral mononuclear cells. A key immunological finding was the presence of likely neutralizing anti-IL-6 autoantibodies which, to the best of our knowledge, have never been reported in patients with IPEX syndrome. Although documented later in the disease course, the latter might explain the Hyper IgE syndrome-like features displayed by the patient, including the allergic manifestations in the absence of hyperactivation of the T helper 2 compartment, as well as the poor inflammatory response during infections. This case extends our knowledge of IPEX syndrome by: i) expanding the spectrum of clinical presentations; ii) revealing a distinct phenotypic signature affecting both T regulatory and T effector cells; iii) suggesting that autoantibodies against cytokines may play a previously underappreciated role in shaping the disease manifestations, not only by driving immune dysregulation and allergy but also by impairing immune defense against infections.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1660161","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T05:35:01Z","timestamp":1756964101000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Case report: anti-IL-6 autoantibodies in a patient with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome"],"prefix":"10.3389","volume":"16","author":[{"given":"Tiziana","family":"Lorenzini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Malmstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ola","family":"Sabet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha","family":"Milanesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Tintor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Severin","family":"Walser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julius","family":"K\u00f6ppen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maarja","family":"Soomann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathias","family":"Hauri-Hohl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seraina","family":"Prader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainer","family":"Doffinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana","family":"Pachlopnik Schmid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.jaci.2023.11.021","article-title":"IPEX syndrome from diagnosis to cure, learning along the way","volume":"153","author":"Bacchetta","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/83713","article-title":"The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3","volume":"27","author":"Bennett","year":"2001","journal-title":"Nat Genet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-00910-8","article-title":"Single-cell analysis of FOXP3 deficiencies in humans and mice unmasks intrinsic and extrinsic CD4+ T cell perturbations","volume":"22","author":"Zemmour","year":"2021","journal-title":"Nat Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/nyas.13011","article-title":"From IPEX syndrome to FOXP3 mutation: a lesson on immune dysregulation","volume":"1417","author":"Bacchetta","year":"2018","journal-title":"Ann N Y Acad Sci"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.643094","article-title":"Atypical presentations of IPEX: expect the unexpected","volume":"9","author":"Consonni","year":"2021","journal-title":"Front Pediatr"},{"key":"B6","doi-asserted-by":"publisher","first-page":"113018","DOI":"10.1016\/j.celrep.2023.113018","article-title":"Mutations from patients with IPEX ported to mice reveal different patterns of FoxP3 and Treg dysfunction","volume":"42","author":"Leon","year":"2023","journal-title":"Cell Rep"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2402","article-title":"Transcription factor Foxp3 and its protein partners form a complex regulatory network","volume":"13","author":"Rudra","year":"2012","journal-title":"Nat Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02411","article-title":"Clinical, immunological, and molecular heterogeneity of 173 patients with the phenotype of immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome","volume":"9","author":"Gambineri","year":"2018","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2012.00211","article-title":"Immune dysregulation, polyendocrinopathy, enteropathy, x-linked syndrome: a paradigm of immunodeficiency with autoimmunity","volume":"31","author":"Barzaghi","year":"2012","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"669298","DOI":"10.3389\/fped.2021.669298","article-title":"IL-2 signaling axis defects: how many faces","volume":"9","author":"Consonni","year":"2021","journal-title":"Front Pediatr"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-022-01352-z","article-title":"The 2022 update of IUIS phenotypical classification for human inborn errors of immunity","volume":"42","author":"Bousfiha","year":"2022","journal-title":"J\u00a0Clin Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40246-023-00451-1","article-title":"SpliceAI-visual: a free online tool to improve SpliceAI splicing variant interpretation","volume":"17","author":"de Sainte Agathe","year":"2023","journal-title":"Hum Genomics"},{"key":"B13","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41586-023-06045-0","article-title":"A genomic mutational constraint map using variation in 76,156 human genomes","volume":"625","author":"Chen","year":"2024","journal-title":"Nature"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201747445","article-title":"Somatic and germline FOXP3 mosaicism in the mother of a boy with IPEX syndrome","volume":"48","author":"Lin","year":"2018","journal-title":"Eur J Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2017.37","article-title":"Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria","volume":"19","author":"Nykamp","year":"2017","journal-title":"Genet Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz972","article-title":"ClinVar: improvements to accessing data","volume":"48","author":"Landrum","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3838","article-title":"Targeting eosinophils in allergy, inflammation and beyond","volume":"12","author":"Fulkerson","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2389","article-title":"Identification of T helper type 1-like, Foxp3+ regulatory T cells in human autoimmune disease","volume":"17","author":"Dominguez-Villar","year":"2011","journal-title":"Nat Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00544","article-title":"Neutralizing anti-cytokine autoantibodies against interferon-\u03b1 in immunodysregulation polyendocrinopathy enteropathy X-linked","volume":"9","author":"Rosenberg","year":"2018","journal-title":"Front Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.jaci.2017.10.041","article-title":"Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study","volume":"141","author":"Barzaghi","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/j.1365-3083.2008.02055","article-title":"A remarkable depletion of both na\u00efve CD4+ and CD8+ with high proportion of memory T cells in an IPEX infant with a FOXP3 mutation in the forkhead domain","volume":"68","author":"Costa-Carvalho","year":"2008","journal-title":"Scand J Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s10875-015-0218-5","article-title":"Immune dysregulation syndromes (IPEX, CD27 deficiency, and others): always doomed from the start","volume":"36","author":"Seidel","year":"2016","journal-title":"J Clin Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1016\/j.jaci.2018.03.015","article-title":"Role of human forkhead box P3 in early thymic maturation and peripheral T-cell homeostasis","volume":"142","author":"Santoni de Sio","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0904076","article-title":"CD4+CD25+Foxp3+ regulatory T cells optimize diversity of the conventional T cell repertoire during reconstitution from lymphopenia","volume":"184","author":"Winstead","year":"2010","journal-title":"J Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41423-019-0316-z","article-title":"FOXP3 protects conventional human T cells from premature restimulation-induced cell death","volume":"18","author":"Voss","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2018.10.005","article-title":"Hypogammaglobulinemia with decreased class-switched B-cells and dysregulated T-follicular-helper cells in IPEX syndrome","volume":"197","author":"Shamriz","year":"2018","journal-title":"Clin Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jaci.2022.09.013","article-title":"Epigenetic and immunological indicators of IPEX disease in subjects with FOXP3 gene mutation","volume":"151","author":"Narula","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e85935","DOI":"10.1172\/jci.insight.85935","article-title":"PD-1 marks dysfunctional regulatory T cells in Malignant gliomas","volume":"1","author":"Lowther","year":"2016","journal-title":"JCI Insight"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000001278","article-title":"CD45RA distinguishes CD4+CD25+CD127-\/low TSDR demethylated regulatory T cell subpopulations with differential stability and susceptibility to tacrolimus-mediated inhibition of suppression","volume":"101","author":"Arroyo Hornero","year":"2017","journal-title":"Transplantation"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1172\/JCI19441","article-title":"Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells","volume":"112","author":"Walker","year":"2003","journal-title":"J Clin Invest"},{"key":"B31","doi-asserted-by":"publisher","first-page":"eabh0891","DOI":"10.1126\/sciimmunol.abh0891","article-title":"The expansion of human T-bethighCD21low B cells is T cell dependent","volume":"6","author":"Keller","year":"2021","journal-title":"Sci Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e20211387","DOI":"10.1084\/jem.20211387","article-title":"Human autoantibodies underlying infectious diseases","volume":"219","author":"Puel","year":"2022","journal-title":"J Exp Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1097\/ACI.0000000000001033","article-title":"Expanding the spectrum of IPEX: from new clinical findings to novel treatments","volume":"24","author":"Voarino","year":"2024","journal-title":"Curr Opin Allergy Clin Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1660161\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T05:35:03Z","timestamp":1756964103000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1660161\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,4]]},"references-count":33,"alternative-id":["10.3389\/fimmu.2025.1660161"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1660161","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,4]]},"article-number":"1660161"}}